CHD1 and cancer: Given that doxorubicin, a commonly used anti-cancer drug, enhances nucleosome turnover, the identification of Chd1 in directing nucleosome turnover provides a mechanistic basis for its tumor suppressor role and may indicate the molecular basis for carcinogenesis in the absence of Chd1 (Huang et al., 2012; Liu et al., 2012; Yang et al., 2013).